(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...
School of Engineering, University of Borås, SE-50190 Borås, Sweden, Chemical and Biological Engineering, Chalmers University of Technology, SE-41296 Göteborg, Sweden, Department of Clinical ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Contribute to TruthOriginem/Starsector-Localization-CN development by creating an account on GitHub.